Cardinal Health, Inc. (CAH) Institutional Ownership & Insider Trading
1,492 institutions reported holding Cardinal Health, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 35 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CAHCardinal Health, Inc.Follow CAH — free
—
Price chart with a free account
- Market cap
- 58.0B
- P/E TTM
- 34.5
- Dividend yield
- 0.8%
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters1,492 institutions held 88.7% of the shares. Across filers that reported both quarters, shares held changed +0.4%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 1,492 | 206 | +0.4% | 447 | 112 | 483 | 70 |
| Mar 26 | 1,412 | 200 | -1.7% | 456 | 107 | 432 | 72 |
| Dec 25 | 1,371 | 207 | -3.1% | 365 | 181 | 401 | 50 |
| Sep 25 | 1,191 | 208 | +3.7% | 354 | 78 | 377 | 93 |
| Jun 25 | 1,226 | 205 | -1.6% | 368 | 149 | 375 | 48 |
| Mar 25 | 1,120 | 205 | -1.4% | 335 | 112 | 353 | 59 |
| Dec 24 | 1,063 | 209 | -2.3% | 310 | 93 | 312 | 61 |
| Sep 24 | 983 | 207 | -4.6% | 274 | 61 | 357 | 64 |
Cardinal Health, Inc. — questions
- Who owns Cardinal Health, Inc. stock?
- 1,492 institutions reported Cardinal Health, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (11.4%), VANGUARD CAPITAL MANAGEMENT LLC (6.6%), WELLINGTON MANAGEMENT GROUP LLP (6.4%).
- Are Cardinal Health, Inc. insiders buying or selling?
- 35 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from Cardinal Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.